Integrative analysis reveals C3 downregulation associated with promoter methylation and immune context in prostate cancer
American Journal of Clinical and Experimental Urology · 2026 · 14 (5) · 204-214
DOI: 10.62347/kors7891 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Urology, 2026. Verfasst von Kanako Matsuoka und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Matsuoka, K., Fang, Q., Mohammed, T. A., Askarpour, M. R., Luo, H., Zhou, J., Kojima, Y., Yoshimura, N., & Wang, Z. (2026). Integrative analysis reveals C3 downregulation associated with promoter methylation and immune context in prostate cancer. American Journal of Clinical and Experimental Urology, 14(5), 204-214. https://doi.org/10.62347/kors7891
Vancouver
Matsuoka K, Fang Q, Mohammed TA, Askarpour MR, Luo H, Zhou J, et al. Integrative analysis reveals C3 downregulation associated with promoter methylation and immune context in prostate cancer. American Journal of Clinical and Experimental Urology. 2026;14(5):204-214. doi:10.62347/kors7891
BibTeX
@article{Matsuoka2026,
author = {Matsuoka, Kanako and Fang, Qinghua and Mohammed, Tanveer Ahmed and Askarpour, Mohammad Reza and Luo, Hong and Zhou, Jianhua and Kojima, Yoshiyuki and Yoshimura, Naoki and Wang, Zhou},
title = {Integrative analysis reveals C3 downregulation associated with promoter methylation and immune context in prostate cancer},
journal = {American Journal of Clinical and Experimental Urology},
year = {2026},
volume = {14},
number = {5},
pages = {204--214},
doi = {10.62347/kors7891}
}
EUVIMED